← Back to Search

Soft Bifocal Contact Lens

Soft Bifocal Contact Lenses for Near-sightedness (BLINK2 Trial)

N/A

Waitlist Available

Led By Jeffrey J Walline, OD PhD

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Participants in the BLINK Study

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up two years

Awards & highlights

No Placebo-Only Group

Summary

This trial is investigating if soft bifocal contact lenses can help slow myopia progression.

Who is the study for?

This trial is for individuals who were part of the BLINK Study, focusing on those with near-sightedness (myopia). It aims to identify biological factors that could predict which patients will benefit most from myopia control using soft bifocal contact lenses.

What is being tested?

The study tests if wearing soft bifocal contact lenses can slow down the worsening of near-sightedness. The research hinges on earlier findings; if prior results show a 30% improvement, this trial will explore additional benefits and mechanisms.

What are the potential side effects?

While specific side effects are not detailed here, typical concerns with contact lens use include eye discomfort, dry eyes, redness, and potential infection. These aspects may be monitored as part of the study's safety measures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ two years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~two years

This trial's timeline: 3 weeks for screening, Varies for treatment, and two years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

The statistical correlation between Light levels and axial length

The statistical correlation between choroidal thickness and axial length

The statistical correlation between iPRGC activity and axial length

Secondary study objectives

Accommodative amplitude

Accommodative facility

Lag of accommodation

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Contact lensExperimental Treatment1 Intervention

Depending upon the study lens proven to be the most effective in the BLINK Study, this contact lens will be used for the first two years of the study. The last year of the study, all subjects will be wearing single vision contact lenses.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Contact lenses

2009

N/A

~1210

0 / 1Eligibility criteria met